Circular 6 February 2026: Availability of New Antiretroviral Products - Paediatric Abacavir/Lamivudine/Dolutegravir (60mg/30mg/5mg)
The South African Government is committed to providing simplified antiretroviral treatment (ART) options to all patients, including children. This is done to ensure access to treatment for children with different needs with the aim of achieving and sustaining optimal viral suppression while avoiding complex treatment regimens, high pill burdens, and caregiver fatigue. This circular serves to
The South African Government is committed to providing simplified antiretroviral treatment (ART) options to all patients, including children. This is done to ensure access to treatment for children with different needs with the aim of achieving and sustaining optimal viral suppression while avoiding complex treatment regimens, high pill burdens, and caregiver fatigue. This circular serves to inform provinces, districts, clinical managers, pharmacists, and healthcare workers of pALD availability, clinical indications, dosing guidance, transition planning, and procurement considerations.